We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-3.85%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$140B
AUM Growth
+$5.37B
Cap. Flow
+$13.5B
Cap. Flow %
9.64%
Top 10 Hldgs %
30.28%
Holding
6,714
New
321
Increased
2,151
Reduced
2,607
Closed
759

Sector Composition

Rank Sector Weight
1 Technology 8.94%
2 Healthcare 5.53%
3 Financials 5.03%
4 Consumer Discretionary 4.6%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMAQR
5501
CALL
DELISTED
Deep Medicine Acquisition Corp. Rights
DMAQR
$1K ﹤0.01%
36,201
RAIN
5502
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$1K ﹤0.01%
224
-215
-49% -$1.35K
ORTX
5503
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1K ﹤0.01%
118
-4,955
-98% -$27.6K
AMTI
5504
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$1K ﹤0.01%
634
-240
-27% -$424
LVOX
5505
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$1K ﹤0.01%
337
-1,061
-76% -$2.24K
PATI
5506
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$1K ﹤0.01%
115
-180
-61% -$1.39K
AENZ
5507
DELISTED
Aenza S.A.A.
AENZ
$1K ﹤0.01%
300
ROSE
5508
DELISTED
Rose Hill Acquisition Corporation Class A Ordinary Shares
ROSE
$1K ﹤0.01%
+100
New +$1.01K
THRN
5509
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$1K ﹤0.01%
210
-814
-79% -$4.09K
MKUL
5510
DELISTED
Molekule Group, Inc. Common Stock
MKUL
$1K ﹤0.01%
278
-697
-71% -$4.21K
DBTX
5511
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$1K ﹤0.01%
291
-1,878
-87% -$8.54K
BRDS
5512
DELISTED
Bird Global, Inc.
BRDS
$1K ﹤0.01%
104
-375
-78% -$4.43K
INFI
5513
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1K ﹤0.01%
1,206
-3,015
-71% -$3.25K
PRDS
5514
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$1K ﹤0.01%
521
-1,261
-71% -$3.76K
MTEM
5515
DELISTED
Molecular Templates, Inc.
MTEM
$1K ﹤0.01%
57
-36
-39% -$453
HMPT
5516
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$1K ﹤0.01%
467
-1,902
-80% -$5.82K
SPPI
5517
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1K ﹤0.01%
2,064
-2,096
-50% -$2.06K
BGRY
5518
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$1K ﹤0.01%
738
-3,036
-80% -$6.06K
BBLN
5519
DELISTED
Babylon Holdings Limited
BBLN
$1K ﹤0.01%
109
-335
-75% -$6.85K
TCRR
5520
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$1K ﹤0.01%
459
-576
-56% -$1.67K
BNNRW
5521
CALL
DELISTED
Banner Acquisition Corp. Warrants
BNNRW
$1K ﹤0.01%
12,151
TIG
5522
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$1K ﹤0.01%
343
-5,303
-94% -$25.1K
CIH
5523
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$1K ﹤0.01%
599
BOXD
5524
DELISTED
Boxed, Inc.
BOXD
$1K ﹤0.01%
1,555
-97,555
-98% -$142K
CRZNW
5525
CALL
DELISTED
Corazon Capital V838 Monoceros Corp Warrant
CRZNW
$1K ﹤0.01%
16,667

Similar funds

Citigroup's Q3 2022 Portfolio in Review

As of Q3 2022, Citigroup held 6,714 positions worth $140B, up 4% from $134B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citigroup deployed $13.5B of net new capital in Q3 2022, opening 321 new positions and adding to 2,151 existing holdings. Its largest new stake was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.31B trimmed.

  • Citigroup's largest Q3 2022 buy was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
  • Citigroup added most to Lowe's Companies in Q3 2022, an estimated $539M increase.
  • Citigroup's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.31B.
  • Citigroup fully exited GCP Applied Technologies Inc. in Q3 2022, selling an estimated $18.7M.
  • Citigroup's ten largest holdings make up 30% of its $140B portfolio in Q3 2022.
  • Citigroup opened 321 new positions and closed 759 in Q3 2022.
  • Citigroup's portfolio value rose 4% quarter-over-quarter to $140B.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.